Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s share price was down 12.4% during trading on Monday . The stock traded as low as GBX 1.53 ($0.02) and last traded at GBX 1.53 ($0.02). Approximately 1,131,357 shares traded hands during mid-day trading, a decline of 4% from the average daily volume of 1,177,392 shares. The stock had previously closed at GBX 1.75 ($0.02).
Cizzle Biotechnology Stock Performance
The firm has a market cap of £6.34 million, a PE ratio of -160.00 and a beta of 0.38. The firm’s 50-day moving average price is GBX 1.89 and its two-hundred day moving average price is GBX 1.85.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Recommended Stories
- Five stocks we like better than Cizzle Biotechnology
- 3 Best Fintech Stocks for a Portfolio Boost
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- Learn Technical Analysis Skills to Master the Stock Market
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
